TickerFacts.

Kestra Medical Technologies, Ltd. (KMTS): Shareholders' Equity

Annual figures by period end, from SEC filings.

$259.66M
As of 2026-04-30
$222.36M
As of 2026-07-31
2024-04-30: -$209.38M2025-04-30: $205.41M2026-04-30: $259.66M$259.66M
2024-04-30 Shareholders' Equity (USD) 2026-04-30
Period endedShareholders' EquityChange YoYSource filing
2026-04-30$259.66M+26.4%2026-07-14, Balance as of period end
2025-04-30$205.41Mn/m2026-07-14, Balance as of period end
2024-04-30-$209.38Mn/a2025-07-17, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
Kestra Medical Technologies, Ltd. (KMTS)2026-04-30$259.66M+26.4%
NeuroPace Inc (NPCE)2025-12-31$19.03M+137.5%
Pulmonx Corp (LUNG)2025-12-31$54.12M-36.9%
Beta Bionics, Inc. (BBNX)2025-12-31$287.61Mn/m
Delcath Systems, Inc. (DCTH)2025-12-31$111.22M+61.8%
Iradimed Corp (IRMD)2025-12-31$94.62M+9.0%
TELA Bio, Inc. (TELA)2025-12-31$6.31M-77.8%
Anika Therapeutics, Inc. (ANIK)2025-12-31$143.47M-6.8%
Orasure Technologies Inc (OSUR)2025-12-31$340.83M-16.9%

Compare KMTS, NPCE, LUNG, BBNX side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗